Hyperglycemia-induced mitochondrial dysfunction contributes to sensory neuron pathology in diabetic neuropathy. Although Schwann cells (SCs) also undergo substantial degeneration in diabetic ...

Blue Label Telecom investors cheered news of plans to list subsidiary Cell C on the Johannesburg Stock Exchange, and the share price increased by 11.18% on Friday afternoon.. Blue Label’s ...

LANSING, Mich. — As the average American consumes 327 pounds of meat annually, the future of meat production is poised for transformation with the advent of cul ...

Electron transfer in cellular respiration, vital to all living organisms, operates through a complex and synchronized network of molecular interactions. Traditional in vitro experiments have provided ...

Blue Label reveals plan to repay R175m Cell C debt By Admire Moyo, ITWeb news editor.Johannesburg, 20 Feb 2025Blue Label has a non-controlling 49.5% stake in Cell C. (Photograph by Lesley Moyo ...

JSE-listed Blue Label Telecoms joint CEO Brett Levy on Thursday said he was satisfied with the performance of Cell C during the six months to November 31, 2024, as the mobile operator’s ...

Blue Label has a non-controlling 49.5% stake in Cell C, and is looking to get an additional 4.04% stake via TPC in order to get control of South Africa’s fourth-biggest mobile operator.

On January 24, 2025, Blue Label announced that ICASA had approved the transfer of Cell C’s spectrum and network licenses, ...

Reelables new temperature label prevents cold chain and perishables losses with next-level tracking and tracing of dataLONDON, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Reelables announced today a new ...

Reelables new temperature label prevents cold chain and perishables losses with next-level tracking and tracing of data. LONDON, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Reelables announced today a new ...

Reelables new temperature label prevents cold chain and perishables losses with next-level tracking and tracing of dataLONDON, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Reelables announced today a new ...

The Food and Drug Administration (FDA) has approved updated drug labeling for fludarabine phosphate (Fludarabine Phosphate Injection; Sandoz) in the treatment of patients with B-cell chronic ...